deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT01000025

PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer

A Double Blind Placebo Controlled Randomized Trial of PF-804 in Patients With Incurable Stage IIIB/IV Non-Small Cell Lung Cancer After Failure of Standard Therapy for Advanced or Metastatic Disease

Sponsor: NCIC Clinical Trials Group

Conditions Lung Cancer
Updated 11 times since 2017 Last updated: Aug 3, 2023 Started: Dec 23, 2009 Primary completion: Jan 15, 2014 Completion: Nov 27, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01000025, this PHASE3 trial focuses on Lung Cancer and remains completed. Sponsored by NCIC Clinical Trials Group, it has been updated 11 times since 2009, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Aug 2019 · 14 months · monthly snapshotCompleted~Aug 2019 – ~May 2020 · 9 months · monthly snapshotCompleted~May 2020 – ~Jan 2021 · 8 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotCompleted~Dec 2021 – ~Sep 2023 · 21 months · monthly snapshotCompleted~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – ~Dec 2025 · 3 months · monthly snapshotCompleted~Dec 2025 – present · 9 months · monthly snapshotCompleted

Change History

11 versions recorded
  1. Dec 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2025 — Dec 2025 [monthly]

    Completed PHASE3

  3. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  4. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  5. Sep 2023 — Jul 2024 [monthly]

    Completed PHASE3

Show 6 earlier versions
  1. Dec 2021 — Sep 2023 [monthly]

    Completed PHASE3

  2. Jan 2021 — Dec 2021 [monthly]

    Completed PHASE3

  3. May 2020 — Jan 2021 [monthly]

    Completed PHASE3

  4. Aug 2019 — May 2020 [monthly]

    Completed PHASE3

  5. Jun 2018 — Aug 2019 [monthly]

    Completed PHASE3

  6. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Dec 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • NCIC Clinical Trials Group
  • Pfizer
Data source: Canadian Cancer Trials Group

For direct contact, visit the study record on ClinicalTrials.gov .